Research on neurodegenerative diseases using induced pluripotent stem cells

Psychogeriatrics

Volumn 12, Issue 2, 2012, Pages 115-119

  Imamura, Keiko ^a   Inoue, Haruhisa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Disease modelling; IPS cell; Neurodegenerative disease

Indexed keywords

TRANSCRIPTION FACTOR;

BRAIN NERVE CELL; CELL DIFFERENTIATION; DEGENERATIVE DISEASE; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SKIN FIBROBLAST; SOMATIC CELL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CARRIER PROTEINS; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; DRUG DISCOVERY; DYSAUTONOMIA, FAMILIAL; EXONS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MUSCULAR ATROPHY, SPINAL; NEURODEGENERATIVE DISEASES; NEURONS; PARKINSON DISEASE; RNA, MESSENGER; SURVIVAL OF MOTOR NEURON 1 PROTEIN; SURVIVAL OF MOTOR NEURON 2 PROTEIN;

EID: 84862668360     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2011.00394.x     Document Type: Review

References (40)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
2. Takahashi K, Tanabe K, Ohnuki M etal. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
3. Verrijzer CP, Kal AJ, van der Vliet PC. The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain. Genes Dev 1990; 4: 1964-1974.
4. Nichols J, Zevnik B, Anastassiadis K etal. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95: 379-391.
5. Nakagawa M, Koyanagi M, Tanabe K etal. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008; 26: 101-106.
6. Pevny LH, Lovell-Badge R. Sox genes find their feet. Curr Opin Obstet Gynecol 1997; 7: 338-344.
7. Chew JL, Loh YH, Zhang W etal. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 2005; 25: 6031-6046.
8. Walia B, Satija N, Tripathi RP etal. Induced Pluripotent Stem Cells: fundamentals and applications of the reprogramming process and its ramifications on regenerative medicine. Stem Cell Rev 2011; DOI: 10.1007/s12015-011-9279-x [Epub ahead of print].
9. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7: 1074-1082.
10. Wernig M, Meissner A, Cassady JP etal. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008; 2: 10-12.
11. McMahon SB, Wood MA, Cole MD. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 2000; 20: 556-562.
12. Lin CH, Lin C, Tanaka H etal. Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. PLoS ONE 2009; 4: e7839.
13. Huangfu D, Maehr R, Guo W etal. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26: 795-797.
14. Hochedlinger K, Plath K. Epigenetic reprogramming and induced pluripotency. Development 2009; 136: 509-523.
15. Nakagawa M, Takizawa N, Narita M etal. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A 2010; 107: 14152-14157.
16. Okita K, Hong H, Takahashi K etal. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc 2010; 5: 418-428.
17. Loh YH, Agarwal S, Park IH etal. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113: 5476-5479.
18. Aasen T, Raya A, Barrero MJ etal. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 2008; 26: 1276-1284.
19. Polo JM, Liu S, Figueroa ME etal. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010; 28: 848-855.
20. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 2009; 27: 275-280.
21. Zhou J, Su P, Li D, Tsang S, Duan E, Wang F. High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 2010; 28: 1741-1750.
22. Tanabe Y, Jessell TM. Diversity and pattern in the developing spinal cord. Science 1996; 274: 1115-1123.
23. Crossley PH, Martinez S, Martin GR. Midbrain development induced by FGF8 in the chick embryo. Nature 1996; 380: 66-68.
24. Gaspard N, Bouschet T, Hourez R etal. An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature 2008; 455: 351-357.
25. Bissonnette CJ, Lyass L, Bhattacharyya BJ etal. The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells 2011; 29: 802-811.
26. Lee SH, Lumelsky N, Studer L etal. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 2000; 18: 675-679.
27. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002; 110: 385-397.
28. Lewis Wolpert. Principles of Development, Third edn. New York: Oxford University Press, 2007.
29. Su HL, Muguruma K, Matsuo-Takasaki M etal. Generation of cerebellar neuron precursors from embryonic stem cells. Dev Biol 2006; 290: 287-296.
30. Lee G, Chambers SM, Tomishima MJ etal. Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 2010; 5: 688-701.
31. Ebert AD, Yu J, Rose FF etal. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277-280.
32. Lee G, Papapetrou EP, Kim H etal. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009; 461: 402-406.
33. Brichta L, Hofmann Y, Hahbeb E etal. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy. Hum Mol Genet 2003; 12: 2481-2489.
34. Slaugenhaupt SA, Mull J, Leyne M etal. Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 2004; 13: 429-436.
35. Nguyen HN, Byers B, Cord B etal. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011; 8: 267-280.
36. Seibler P, Graziotto J, Jeong H etal. Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci 2011; 31: 5970-5976.
37. Dimos JT, Rodolfa KT, Niakan KK etal. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218-1221.
38. Mitne-Neto M, Machado-Costa M, Marchetto MC etal. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum Mol Genet 2011; 20: 3642-3652.
39. Pang ZP, Yang N, Vierbuchen T etal. Induction of human neuronal cells by defined transcription factors. Nature 2011; 476: 220-223.
40. Qiang L, Fujita R, Yamashita T etal. Directed conversion of Alzheimer's disease patient skin fibroblasts into functional neurons. Cell 2011; 46: 359-371.